SEP holders turn their attention to medtech

Owners of standard essential patents, or SEPs, are increasingly looking to medtech companies for possible licensing arrangements. The sector brings extra challenges for entities looking to enforce their patent rights, with...

Already a subscriber? Click here to view full article